-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
ArticleMedicine Guanlan
According to the latest announcement from the Center for Drug Evaluation (CDE) of the National Food and Drug Administration of China, Hutchison Medicine’s HMPL-653 capsule has just received an implied clinical trial approval and plans to develop treatments for advanced malignant solid tumors and giant cell tumors of tendon sheaths (TGCT)
Image source: CDE official website screenshot
CSF-1R is the cytokine CSF-1 receptor.
Speaking of giant cell tumor of tendon sheath, this is a rare tumor with local aggressiveness
However, for patients with giant cell tumor of tendon sheath, the current main treatment is still surgical resection.
In addition to its role in tendon sheath giant cell tumors, CSF-1R-mediated signaling pathways also play an important role in the differentiation and survival of mononuclear phagocytes, especially macrophages
At present, the global pipeline for CSF-1R access is also continuing to be promoted
Reference materials:
[1] Center for Drug Evaluation (CDE) of China National Medical Products Administration.